Literature DB >> 1415621

Concurrent increases in regional hematocrit and blood flow in diabetic rats: prevention by sorbinil.

S P Sutera1, K Chang, J Marvel, J R Williamson.   

Abstract

These studies were undertaken to investigate the relationship between regional hemodynamic and hemorheological changes in the microvasculature of diabetic rats. Diabetes was induced in male Sprague-Dawley rats by injection of streptozotocin (55 mg/kg body wt). Control rats were injected with vehicle (sodium citrate buffer). A subgroup of diabetic rats was treated with an aldose reductase inhibitor (sorbinil) added to the diet in an amount to provide a daily dose of approximately 0.2 mmol.kg-1.day-1. Three weeks later all animals were anesthetized with thiobutabarbital sodium (Inactin, 100 mg/kg injected intraperitoneally) for assessment of blood flow (by injection of 15 microns microspheres) and regional hematocrit (determined by isotope-dilution techniques using 51Cr-labeled red blood cells and 125I-labeled bovine serum albumin) in selected tissues. The hematocrit in arterial blood samples was identical (approximately 46%) in controls and in diabetics. Regional hematocrits were much lower than arterial hematocrits in control rats and ranged from approximately 20% in ocular tissues, sciatic nerve, diaphragm, and skin to approximately 30% in brain, skeletal muscle, heart, and fat. Hematocrits of diabetic rats were markedly increased in ocular tissues, sciatic nerve, and skin but not in brain, heart, or skeletal muscle. These increases in regional hematocrit were associated with increases in blood flow and were largely prevented by sorbinil. Diabetes induced significant decreases in the mean transit times for whole blood and erythrocytes in all tissues examined except brain, retina, and skin.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1415621     DOI: 10.1152/ajpheart.1992.263.3.H945

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  Diabetic Neuropathies.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-01       Impact factor: 3.598

2.  TLR2 knockout protects against diabetes-mediated changes in cerebral perfusion and cognitive deficits.

Authors:  Trevor Hardigan; Caterina Hernandez; Rebecca Ward; M Nasrul Hoda; Adviye Ergul
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-02-22       Impact factor: 3.619

3.  Ocular haemodynamics and colour contrast sensitivity in patients with type 1 diabetes.

Authors:  O Findl; S Dallinger; B Rami; K Polak; E Schober; A Wedrich; E Ries; H G Eichler; M Wolzt; L Schmetterer
Journal:  Br J Ophthalmol       Date:  2000-05       Impact factor: 4.638

4.  Hyperoxia improves contrast sensitivity in early diabetic retinopathy.

Authors:  A Harris; O Arend; R P Danis; D Evans; S Wolf; B J Martin
Journal:  Br J Ophthalmol       Date:  1996-03       Impact factor: 4.638

5.  Inner retinal oxygen delivery and metabolism in streptozotocin diabetic rats.

Authors:  Justin Wanek; Pang-Yu Teng; Norman P Blair; Mahnaz Shahidi
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-13       Impact factor: 4.799

6.  Quantitation of celecoxib and four of its metabolites in rat blood by UPLC-MS/MS clarifies their blood distribution patterns and provides more accurate pharmacokinetics profiles.

Authors:  Yong Ma; Song Gao; Ming Hu
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2015-07-19       Impact factor: 3.205

7.  Nerve ischaemia in diabetic rats: time-course of development, effect of insulin treatment plus comparison of streptozotocin and BB models.

Authors:  E J Stevens; A L Carrington; D R Tomlinson
Journal:  Diabetologia       Date:  1994-01       Impact factor: 10.122

8.  Perfusion scanning using 99mTc-HMPAO detects early cerebrovascular changes in the diabetic rat.

Authors:  Fatma J Al-Saeedi
Journal:  BMC Med Phys       Date:  2008-03-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.